4.7 Article

Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Brain region-specific myelinogenesis is not directly linked to amyloid-? in APP/PS1 transgenic mice

Shuang-Ling Wu et al.

Summary: Alzheimer's disease (AD) is characterized by the presence of aggregated amyloid beta-protein (Aβ). Recent evidence suggests that inadequate myelinogenesis plays a role in AD-related functional deficits. The relationship between Aβ and myelinogenesis in AD brains, however, remains unclear.

EXPERIMENTAL NEUROLOGY (2023)

Article Multidisciplinary Sciences

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer's disease

Constanze Depp et al.

Summary: The main risk factor for Alzheimer's disease (AD), the leading cause of dementia, is age, but the reasons for this are still poorly understood. In this study, researchers found that age-related structural defects of myelin lead to the formation of amyloid-beta (Aβ) plaques, a hallmark of AD. Improving the health of oligodendrocytes and the integrity of myelin could be a promising target for delaying and slowing the progression of AD.

NATURE (2023)

Review Neurosciences

Early life adversity as a risk factor for cognitive impairment and Alzheimer's disease

Zhihai Huang et al.

Summary: Neurological conditions, such as cognitive impairment and Alzheimer's disease, have a significant impact on society, affecting millions of individuals worldwide. Recent studies suggest that besides genetic factors, environmental and experiential factors may contribute to the development of these diseases. Early life adversity (ELA) has been found to have a profound effect on brain function and health in later life. Research using rodent models has shown that exposure to ELA leads to specific cognitive deficits and worsened pathology related to Alzheimer's disease. There is growing concern about the increased risk of cognitive impairments in individuals with a history of ELA. This review examines evidence from both human and animal studies, focusing on the link between ELA and cognitive impairment and Alzheimer's disease. The findings suggest that ELA, particularly during early postnatal stages, increases susceptibility to cognitive impairment and Alzheimer's disease later in life. Mechanistically, ELA may disrupt the hypothalamus-pituitary-adrenal axis, alter the gut microbiome, cause chronic inflammation, impair oligodendrocyte function, result in hypomyelination, and disrupt adult hippocampal neurogenesis. Crosstalk between these factors may contribute synergistically to cognitive impairment in later life. Additionally, several interventions that could help mitigate the adverse effects of ELA are discussed. Further research in this important area will improve the management of ELA and reduce the burden of related neurological conditions.

TRANSLATIONAL NEURODEGENERATION (2023)

Review Developmental Biology

Oligodendrocytes and myelin: Active players in neurodegenerative brains?

Jing-Fei Chen et al.

Summary: Oligodendrocytes and myelin undergo dynamic changes in healthy and neurodegenerative brains, and may play an important role in modulating neuronal function and survival. Targeting oligodendroglial cells could have potential value in treating neurodegenerative diseases.

DEVELOPMENTAL NEUROBIOLOGY (2022)

Article Endocrinology & Metabolism

Oligodendrocyte precursor cell transplantation promotes angiogenesis and remyelination via Wnt/beta-catenin pathway in a mouse model of middle cerebral artery occlusion

Li-Ping Wang et al.

Summary: Transplantation of oligodendrocyte precursor cells promotes angiogenesis and remyelination after ischemic stroke, improving motor and cognitive function and alleviating brain atrophy.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2022)

Review Biochemistry & Molecular Biology

An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases

Daniel Mihai Teleanu et al.

Summary: This review summarizes the correlation between oxidative stress and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. It also discusses the impact of oxidative stress on the inflammatory response. Antioxidants are considered potential therapeutic options for these disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Geriatrics & Gerontology

Long-term exercise pre-training attenuates Alzheimer's disease-related pathology in a transgenic rat model of Alzheimer's disease

Luodan Yang et al.

Summary: This study found that long-term exercise pretreatment can alleviate learning and memory impairments, as well as anxious-depressive-like behaviors, in transgenic AD rats. Exercise pretreatment also reduced amyloid-beta deposition and tau hyperphosphorylation, preserved dendritic spine density, synapses, and synaptic vesicles, and inhibited neuronal damage and degeneration. Additionally, exercise pretreatment suppressed mitochondrial dynamics imbalance, oxidative stress, and neuroinflammation. These findings suggest that long-term exercise pretreatment may be a potential approach to delay the progression of AD.

GEROSCIENCE (2022)

Article Multidisciplinary Sciences

APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes

Joel W. Blanchard et al.

Summary: APOE4 has widespread effects on gene expression in the human brain, particularly in relation to cholesterol homeostasis and transport. Aberrant cholesterol deposition in oligodendrocytes leads to reduced myelination, while pharmacologically facilitating cholesterol transport improves learning and memory. This study provides insights into the impact of APOE4 on the aging human brain and suggests potential therapeutic strategies for Alzheimer's disease.

NATURE (2022)

Article Biochemistry & Molecular Biology

Brain copper may protect from cognitive decline and Alzheimer's disease pathology: a community-based study

Puja Agarwal et al.

Summary: This study investigates the association between brain copper levels and dietary copper with cognitive decline and AD pathology burden. Higher brain copper levels are associated with slower cognitive decline and less AD pathology. Dietary copper intake is associated with slower cognitive decline, but not with brain copper levels or AD pathology.

MOLECULAR PSYCHIATRY (2022)

Review Nutrition & Dietetics

Targeting Alzheimer's Disease: The Critical Crosstalk between the Liver and Brain

Zhihai Huang et al.

Summary: Alzheimer's disease (AD) is an age-related neurodegenerative disorder that currently lacks a cure. Recent research suggests that liver dysfunction may be an early event in the pathophysiology of AD. The liver's role in the clearance of amyloid-beta (Aβ) and its abnormal physiological processes may contribute to the neurodegeneration seen in AD. In addition, the potential therapeutic role of fibroblast growth factor 21 (FGF21), a product of hepatic synthesis, in AD management is discussed.

NUTRIENTS (2022)

Article Clinical Neurology

Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's disease

Anna Rubinski et al.

Summary: The study found that higher levels of myelination in cortical regions are associated with lower tau-PET uptake, and fiber-tract myelin levels modulate the association between functional connectivity and tau-PET spreading. This suggests that higher myelination levels are linked to lower susceptibility of connected regions to accumulate fibrillar tau.

ALZHEIMERS RESEARCH & THERAPY (2022)

Review Neurosciences

Myelin repair in Alzheimer's disease: a review of biological pathways and potential therapeutics

Lauren Rose Hirschfeld et al.

Summary: This literature review investigates the significant overlap between myelin-repair signaling pathways and pathways known to contribute to hallmark pathologies of Alzheimer's disease, and discusses therapeutic targets and potential research directions.

TRANSLATIONAL NEURODEGENERATION (2022)

Article Clinical Neurology

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti-amyloid therapy

Jeffrey Fessel

Summary: Several anti-amyloid trials have the potential to delay cognitive decline, but none can reverse the progression of Alzheimer's disease (AD). It is suggested that amyloid alone may not be sufficient as a target, and other factors such as myelination and synaptogenesis also need to be addressed. Evidence supports the idea that drugs targeting myelination and synaptogenesis are the optimal partners for anti-amyloid drugs. Clemastine, fingolimod, and rolipram are shown to benefit both myelination and synaptogenesis. Combining these drugs with an anti-amyloid drug may have the potential to reverse AD.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)

Review Cell Biology

Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies

Tao Song et al.

Summary: Evidence suggests that metabolic changes in the brain associated with neuroinflammation, oxidative stress, and mitochondrial dysfunction play a key role in the pathophysiology of MCI and AD. Studies showed decreased levels of N-acetyl aspartate and creatine, increased myo-inositol, decreased glutathione, and disrupted energy metabolism. The hippocampus displayed the most significant alterations in these metabolites.

AGEING RESEARCH REVIEWS (2021)

Article Medical Laboratory Technology

Hemoglobin induces oxidative stress and mitochondrial dysfunction in oligodendrocyte progenitor cells

Chirayu D. Pandya et al.

Summary: Research shows that hemoglobin induces oxidative stress and mitochondrial dysfunction in OPCs, while antioxidant therapy can mitigate these effects. The effects of hemoglobin and phenelzine on OPC proliferation were not statistically significant, but trends suggest hemoglobin reduces OPC proliferation and phenelzine may increase OPC proliferation.

TRANSLATIONAL RESEARCH (2021)

Review Biochemistry & Molecular Biology

Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders

Jan Spaas et al.

Summary: Oligodendrocyte precursor cells (OPCs) play a crucial role in various neurodegenerative disorders, with oxidative/carbonyl stress potentially impacting their differentiation and function, contributing to disease progression. Investigating how oxidative/carbonyl stress disrupts OPC differentiation may offer new directions for therapeutic strategies in neurodegenerative disorders.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Chemistry, Multidisciplinary

A Water-Soluble Peptoid Chelator that Can Remove Cu2+ from Amyloid-β Peptides and Stop the Formation of Reactive Oxygen Species Associated with Alzheimer's Disease

Anastasia E. Behar et al.

Summary: The study introduces a water-soluble peptidomimetic chelator, P3, that selectively removes Cu2+ from Cu-Aβ and prevents the formation of ROS, showing potential advantages in the treatment of AD.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Neurosciences

Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment

Shulan Qiu et al.

Summary: This study investigated the impact of CNS sulfatide deficiency on AD pathology using different mouse models. The results showed that mild sulfatide losses within myelinating cells can activate disease-associated microglia and astrocytes, leading to chronic AD-like neuroinflammation and mild cognitive impairment, with gender differences. Additionally, sulfatide deficiency was found to be an important contributor to neuroinflammation and cognitive impairment in AD.

MOLECULAR NEURODEGENERATION (2021)

Article Neurosciences

Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer's disease

Jing-Fei Chen et al.

Summary: The study found a significant increase in new myelin formation rate in the APP/PS1 mouse model of Alzheimer's disease, despite a decrease in overall myelination levels in the cortex and hippocampus. Enhancing myelin renewal through genetic or pharmacological methods improved cognitive performance in memory-related tasks.

NEURON (2021)

Article Geriatrics & Gerontology

Oligodendrocyte Precursor Cells Transplantation Improves Stroke Recovery via Oligodendrogenesis, Neurite Growth and Synaptogenesis

Wanlu Li et al.

Summary: The transplantation of OPCs has been shown to promote recovery after ischemic stroke by enhancing endogenous oligodendrogenesis, neurite growth, and synaptogenesis, potentially through the Netrin-1/DCC axis.

AGING AND DISEASE (2021)

Article Biochemistry & Molecular Biology

Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology

Scott Ayton et al.

MOLECULAR PSYCHIATRY (2020)

Article Neurosciences

Disruption of Oligodendrogenesis Impairs Memory Consolidation in Adult Mice

Patrick E. Steadman et al.

NEURON (2020)

Article Neurosciences

Preservation of a remote fear memory requires new myelin formation

Simon Pan et al.

NATURE NEUROSCIENCE (2020)

Review Neurosciences

Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease

Sahil Khan et al.

CURRENT NEUROPHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Copper stress induces zebrafish central neural system myelin defects via WNT/NOTCH-hoxb5b signaling and pou3f1/fam168a/fam168b DNA methylation

Ting Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Cross-sectional and Longitudinal Assessment of Brain Iron Level in Alzheimer Disease Using 3-T MRI

Anna Damulina et al.

RADIOLOGY (2020)

Review Neurosciences

Myelin plasticity: sculpting circuits in learning and memory

Wendy Xin et al.

NATURE REVIEWS NEUROSCIENCE (2020)

Review Biochemistry & Molecular Biology

Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications

Grazyna Gromadzka et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Neurosciences

Early neuronal accumulation of DNA double strand breaks in Alzheimer's disease

Niraj M. Shanbhag et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome

Dario Tejera et al.

EMBO JOURNAL (2019)

Article Clinical Neurology

Changes of Myelin Organization in Patients with Alzheimer's Disease Shown by q-Space Myelin Map Imaging

Miho Ota et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Myelin content changes in probable Alzheimer's disease and mild cognitive impairment: Associations with age and severity of neuropsychiatric impairment

Eleftherios Kavroulakis et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)

Article Neurosciences

Oligodendroglia Are Particularly Vulnerable to Oxidative Damage after Neurotrauma In Vivo

Marcus K. Giacci et al.

JOURNAL OF NEUROSCIENCE (2018)

Review Clinical Neurology

Cognition in multiple sclerosis: State of the field and priorities for the future

James F. Sumowski et al.

NEUROLOGY (2018)

Article Multidisciplinary Sciences

Defective cholesterol clearance limits remyelination in the aged central nervous system

Ludovico Cantuti-Castelvetri et al.

SCIENCE (2018)

Editorial Material Clinical Neurology

q-space Myelin Map imaging: A new imaging technique for treatment evaluation in multiple sclerosis

Jun-ichi Kira

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Article Biochemistry & Molecular Biology

Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia

Jingshu Xu et al.

METALLOMICS (2017)

Article Clinical Neurology

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease

Thomas N. Chase et al.

NEUROTHERAPEUTICS (2017)

Review Neurosciences

Myelin dynamics: protecting and shaping neuronal functions

Aiman S. Saab et al.

CURRENT OPINION IN NEUROBIOLOGY (2017)

Article Biochemistry & Molecular Biology

Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron

Foozhan Tahmasebinia et al.

BIOMETALS (2017)

Article Cell Biology

Oligodendrocytes: Myelination and Axonal Support

Mikael Simons et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

Article Multidisciplinary Sciences

Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study

Douglas C. Dean et al.

PLOS ONE (2016)

Review Biochemistry & Molecular Biology

Cholesterol in myelin biogenesis and hypomyelinating disorders

Gesine Saher et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)

Article Clinical Neurology

Components of Myelin Damage and Repair in the Progression of White Matter Pathology After Mild Traumatic Brain Injury

Amanda J. Mierzwa et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)

Article Neurosciences

Anti-Muscarinic Adjunct Therapy Accelerates Functional Human Oligodendrocyte Repair

Kavitha Abiraman et al.

JOURNAL OF NEUROSCIENCE (2015)

Article Geriatrics & Gerontology

The N-terminal region of myelin basic protein reduces fibrillar amyloid-β deposition in Tg-5xFAD mice

Ming-Hsuan Ou-Yang et al.

NEUROBIOLOGY OF AGING (2015)

Review Cell Biology

Myelination of the Nervous System: Mechanisms and Functions

Klaus-Armin Nave et al.

ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 (2014)

Article Clinical Neurology

Myelin Injury and Degraded Myelin Vesicles in Alzheimer's Disease

Xinhua Zhan et al.

CURRENT ALZHEIMER RESEARCH (2014)

Article Medicine, Research & Experimental

Perinatal inflammation results in decreased oligodendrocyte numbers in adulthood

Amanda E. Graf et al.

LIFE SCIENCES (2014)

Review Neurosciences

Oxidative stress in Alzheimer's disease

Zhichun Chen et al.

NEUROSCIENCE BULLETIN (2014)

Article Clinical Neurology

Myelin imaging in amyotrophic and primary lateral sclerosis

Shannon Kolind et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)

Article Neurosciences

Myelin alters the inflammatory phenotype of macrophages by activating PPARs

Jeroen F. J. Bogie et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)

Article Geriatrics & Gerontology

Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro

Makoto Horiuchi et al.

NEUROBIOLOGY OF AGING (2012)

Article Cell Biology

Human Neural Stem Cells Induce Functional Myelination in Mice with Severe Dysmyelination

Nobuko Uchida et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Article Cell Biology

Neural Stem Cell Engraftment and Myelination in the Human Brain

Nalin Gupta et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Review Biochemistry & Molecular Biology

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeutics

Peizhong Mao et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)

Review Clinical Neurology

Oligodendrocytes: biology and pathology

Monika Bradl et al.

ACTA NEUROPATHOLOGICA (2010)

Article Clinical Neurology

Focal demyelination in Alzheimer's disease and transgenic mouse models

Stanislaw Mitew et al.

ACTA NEUROPATHOLOGICA (2010)

Review Medicine, Research & Experimental

Biomarkers of oxidative damage and inflammation in Alzheimer's disease

Douglas Galasko et al.

BIOMARKERS IN MEDICINE (2010)

Article Pediatrics

Neuropathology of Menkes' Disease

R. O. Barnard et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)

Article Biochemistry & Molecular Biology

N-terminal Domain of Myelin Basic Protein Inhibits Amyloid β-Protein Fibril Assembly

Mei-Chen Liao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Degradation of Amyloid β Protein by Purified Myelin Basic Protein

Mei-Chen Liao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Medicine, General & Internal

Neonatal diagnosis and treatment of Menkes disease

Stephen G. Kaler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Cell & Tissue Engineering

Stem cell-derived therapeutic myelin repair requires 7% cell replacement

Mary E. Kiel et al.

STEM CELLS (2008)

Article Biochemistry & Molecular Biology

Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimers disease

Mark A. Lovell et al.

NUCLEIC ACIDS RESEARCH (2007)

Article Clinical Neurology

Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis

Suhayl Dhib-Jalbut

NEUROLOGY (2007)

Article Clinical Neurology

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis

C. Wegner et al.

NEUROLOGY (2006)

Article Clinical Neurology

Elevated cortical zinc in Alzheimer disease

D. Religa et al.

NEUROLOGY (2006)

Review Clinical Neurology

Cholesterol in Alzheimer's disease

LA Shobab et al.

LANCET NEUROLOGY (2005)

Article Multidisciplinary Sciences

Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice

BJ Cummings et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Endocrinology & Metabolism

Downregulation of myelination, energy, and translational genes in Menkes disease brain

PC Liu et al.

MOLECULAR GENETICS AND METABOLISM (2005)

Article Clinical Neurology

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis

J Brettschneider et al.

MULTIPLE SCLEROSIS JOURNAL (2005)

Article Neurosciences

High cholesterol level is essential for myelin membrane growth

G Saher et al.

NATURE NEUROSCIENCE (2005)

Article Developmental Biology

Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice

RP Skoff et al.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2001)

Article Neurosciences

Amyloid-beta peptides are cytotoxic to oligodendrocytes

J Xu et al.

JOURNAL OF NEUROSCIENCE (2001)

Article Medicine, Research & Experimental

Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease

SM de la Monte et al.

LABORATORY INVESTIGATION (2000)

Article Clinical Neurology

Increased cerebrospinal fluid tau protein in multiple sclerosis

E Kapaki et al.

EUROPEAN NEUROLOGY (2000)